Literature DB >> 35982358

Sleep disturbance among breast cancer survivors and controls from midlife to early older adulthood: Pink SWAN.

Neha Goyal1, Beverly J Levine2, Sybil L Crawford3, Nancy E Avis4.   

Abstract

PURPOSE: To compare sleep disturbance from 5 years pre- to 5 years post-diagnosis between breast cancer survivors (BCS) and women without cancer over the same period and to identify BCS subgroups exhibiting different sleep trajectories.
METHODS: Analyses included data from 152 BCS and 2163 controls from 20 years of follow-up in the longitudinal Study of Women's Health Across the Nation (SWAN), a multi-racial/ethnic cohort study. SWAN participants were assessed approximately annually from 1995 to 2015 using a standardized protocol. Pink SWAN focused on women who reported no cancer at SWAN enrollment and developed incident breast cancer after enrollment or did not develop breast cancer. Nonparametric locally weighted scatterplot smoothing plots and linear mixed models were used to compare the prevalence of the most frequently reported sleep problem, frequently waking several times a night (a sleep maintenance problem) during the previous 2 weeks, between BCS and controls in the 5 years pre- to 5 years post-diagnosis. We characterized heterogeneity among BCS on this sleep problem using group-based trajectories and examined pre-diagnosis variables as predictors of group membership.
RESULTS: No differences were found between BCS and controls in prevalence of frequent nighttime awakenings either before or after diagnosis. Among BCS, three trajectory groups were identified. Thirty-seven percent of BCS had consistently low prevalence of waking several times per night, 30% had high prevalence, and 33% had increasing prevalence which started 2 years pre-diagnosis. Prevalence of pre-diagnosis vasomotor symptoms, anxiety, depressive symptoms, and smoking differed among these groups.
CONCLUSION: Among mid-aged women diagnosed with breast cancer, this diagnosis did not trigger/amplify a sleep maintenance problem. The majority of BCS had similar levels of this sleep problem from pre- to post-diagnosis. IMPLICATIONS FOR CANCER SURVIVORS: Although sleep maintenance problems were not amplified by a cancer diagnosis, a subset of BCS may have sleep issues that should be monitored and treated, as indicated.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breast; Cancer; Longitudinal; Sleep; Survivors

Year:  2022        PMID: 35982358     DOI: 10.1007/s11764-022-01247-3

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.062


  22 in total

1.  Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms.

Authors:  Laura Lampio; Päivi Polo-Kantola; Olli Polo; Tommi Kauko; Jenni Aittokallio; Tarja Saaresranta
Journal:  Menopause       Date:  2014-11       Impact factor: 2.953

2.  Cancer treatment and survivorship statistics, 2019.

Authors:  Kimberly D Miller; Leticia Nogueira; Angela B Mariotto; Julia H Rowland; K Robin Yabroff; Catherine M Alfano; Ahmedin Jemal; Joan L Kramer; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2019-06-11       Impact factor: 508.702

Review 3.  Prevalence and risk factors of sleep disturbances in breast cancersurvivors: systematic review and meta-analyses.

Authors:  Laurence Leysen; Astrid Lahousse; Jo Nijs; Nele Adriaenssens; Olivier Mairesse; Sergei Ivakhnov; Thomas Bilterys; Eveline Van Looveren; Roselien Pas; David Beckwée
Journal:  Support Care Cancer       Date:  2019-07-25       Impact factor: 3.603

4.  Trajectories of sleep quality during the first three years after breast cancer diagnosis.

Authors:  Filipa Fontes; Milton Severo; Marta Gonçalves; Susana Pereira; Nuno Lunet
Journal:  Sleep Med       Date:  2017-04-04       Impact factor: 3.492

5.  Sex differences in insomnia: a meta-analysis.

Authors:  Bin Zhang; Yun-Kwok Wing
Journal:  Sleep       Date:  2006-01       Impact factor: 5.849

6.  Depression and vasomotor symptoms in young breast cancer survivors: the mediating role of sleep disturbance.

Authors:  Eynav E Accortt; Julienne E Bower; Annette L Stanton; Patricia A Ganz
Journal:  Arch Womens Ment Health       Date:  2015-01-18       Impact factor: 3.633

7.  Distinct Trajectories of Fatigue and Sleep Disturbance in Women Receiving Chemotherapy for Breast Cancer.

Authors:  Meagan Whisenant; Bob Wong; Sandra A Mitchell; Susan L Beck; Kathi Mooney
Journal:  Oncol Nurs Forum       Date:  2017-11-01       Impact factor: 2.172

Review 8.  Impact of breast cancer treatments on sleep disturbances - A systematic review.

Authors:  Ana Rute Costa; Filipa Fontes; Susana Pereira; Marta Gonçalves; Ana Azevedo; Nuno Lunet
Journal:  Breast       Date:  2014-10-11       Impact factor: 4.380

9.  Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women's Health Initiative.

Authors:  Chloe M Beverly; Michelle J Naughton; Michael L Pennell; Randi E Foraker; Gregory Young; Lauren Hale; Elizabeth M Cespedes Feliciano; Kathy Pan; Tracy E Crane; Suzanne C Danhauer; Electra D Paskett
Journal:  NPJ Breast Cancer       Date:  2018-06-29

10.  Factors associated with sleep disturbances in women undergoing treatment for early-stage breast cancer.

Authors:  Susan Grayson; Susan Sereika; Caroline Harpel; Emilia Diego; Jennifer G Steiman; Priscilla F McAuliffe; Susan Wesmiller
Journal:  Support Care Cancer       Date:  2021-07-10       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.